Patent · US Active

Humanized antibody compositions and methods for binding lysophosphatidic acid

US8604172B2 · kind B2 · utility

4Cited by
28References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2010
Grant dateDec 10, 2013
Priority date—
Expiry dateJul 10, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for making and using humanized anti-LPA monoclonal antibodies, and fragments and derivatives thereof, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.